CTIS2024-513328-40-00
Recruiting
Phase 1
SHORTCUT - Efficacy of 7 days versus 14 days of antibiotic therapy for acute pyelonephritis in kidney transplant recipients, a multicenter randomized non-inferiority trial - APHP200020
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Pyelonephritis, Kidney Transplant recipients
- Sponsor
- Assistance Publique Hopitaux De Paris
- Enrollment
- 470
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age \>18 years Kidney Transplant Recipients, APN defined by: fever (T°\=38°C) (with or without clinical signs and/or symptoms of UTI) and pyuria (\=104 white blood cells/mL or \=10/mm3\) and positive urine culture (uropathogen \=103 CFU/mL susceptible to the empirically administrated antibiotic), No confirmed or suspected febrile non urinary bacterial infection, No urologic/renal complication at baseline imaging (abscess, obstruction...), Favourable early response to antibiotic treatment:( 48 to 60 hours after the first dose of antibiotic effective against the causative uropathogen) defined by: T°\<38°C and improvement (or resolution) of signs and/or symptoms of urinary tract infection if present at diagnosis., Written informed consent
Exclusion Criteria
- •Patients with any of the following conditions, First month post transplantation, \-Current indwelling catheter (including bladder catheter, ureteral stents, percutaneous nephrostomy tubes), Neurogenic bladder, Enterocystoplasty, Immunodeficiency or immunosuppressive therapy not related to kidney transplantation, including hematologic malignancy, cancer, asplenia, neutropenia\<500 neutrophils/mm3,, Pregnancy, breastfeeding, Hypersensitivity or previous severe adverse drug reaction to the antibiotic therapy, Unable or unwilling, in the judgment of the investigator, to comply with the protocol, Life expectancy\<1 month, Patient under legal guardianship or without healthcare coverage, Severe or complicated condition, Homeless patient, Women with childbearing potential not using adequate contraception, Any rapidly progressing disease or immediately life\-threatening illness, including, but not limited to, septic shock, current or impeding respiratory failure, acute heart or liver failure, Admission or stay in intensive care unit at baseline, Obstruction of the urinary tract, Renal, perinephric or prostatic abscess, prior inclusion in this study, current participation to another interventional study, Dual antibiotic therapy ((prophylactic antibiotic such as cotrimoxazole allowed) )(only 1 dose of aminoside is allowed before randomization)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
To compare 7 days vs 14 days of antibiotics in neonatal bacterial infections.Health Condition 1: P369- Bacterial sepsis of newborn, unspecifiedCTRI/2022/08/044933AIIMS Raipur
Completed
Phase 3
To compare whether a 1 week course of antibiotics is as good as 2 weeks of antibiotics for septic newborn babiesHealth Condition 1: P369- Bacterial sepsis of newborn, unspecifiedHealth Condition 2: null- Neonatal bacterial septicemiaCTRI/2017/09/009743Indian Council of Medical Research261
Not yet recruiting
Not Applicable
Is 7 days of antibiotics as effective as 14 days of antibiotics for the 'cure' of urinary sepsis: an observational sub-study of the BALANCE Study.rinary tract infectionUrinary sepsisBacteraemiaUrinary tract infectionInfection - Studies of infection and infectious agentsRenal and Urogenital - Other renal and urogenital disordersACTRN12620001108909Monash University284
Not yet recruiting
Phase 3
A clinical trial to compare the role of 14 days vs 21 days iv antibiotic in neonates with uncomplicated meningitis.Health Condition 1: G009- Bacterial meningitis, unspecifiedCTRI/2023/06/053614Moti Lal Nehru Medical CollegePrayagraj
Recruiting
Not Applicable
Effectiveness of 7-day and 14-day high-dose PPI bismuth-containing quadruple therapy with probiotics supplement for Helicobacter pylori eradication: A double blinded-randomized placebo-controlled studyEffectiveness of 7-day and 14-day high-dose PPI bismuth-containing quadruple therapy with probiotics supplement for Helicobacter pylori eradicationTCTR20190127003Thammasat University100